Status:
COMPLETED
Incidence of HANA Conditions in HIV-infected Individuals
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
HIV
Metabolic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
With the availability of effective anti-retroviral therapy, HIV-infected individuals are expected not to die of AIDS and have longer life expectancy. But at the same time, HIV-associated non-AIDS (HAN...
Detailed Description
This is a prospective, longitudinal, cohort study. 150 newly diagnosed HIV-infected individuals attending HIV clinics in Hong Kong will be recruited. Clinical assessment, and laboratory and imaging st...
Eligibility Criteria
Inclusion
- Confirmed HIV infection by HIV antibody or RNA test
- Age ≥18 years old
- Anti-retroviral treatment naïve
- Agree to initiate anti-retroviral therapy (ART) as determined by in-charge HIV physician
Exclusion
- Pregnancy
- Unable to give informed consent
Key Trial Info
Start Date :
April 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT03483584
Start Date
April 6 2018
End Date
September 30 2024
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Shatin, Hong Kong